InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,995.54
(
0.38%
)
US TECH 100
20,562.00
(
0.10%
)
Dow Jones
43,988.99
(
0.59%
)
Brent Oil
73.89
(
0.00%
)
Bitcoin
76,898.90
(
0.43%
)
Post# of 4764
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biophud

Send PM Follow Ignore
Followers 0
Posts 394
Boards Moderated 0
Alias Born 08/12/2006

biophud

Re: None

Friday, 07/06/2007 10:10:32 PM

Friday, July 06, 2007 10:10:32 PM

Post# of 4764
Very interesting clinical trial (IMO). Genentech is testing Apomab with Erbitux.
Background--Apomab is an agonistic MAB that targets death receptor 5 (AMGN and HGSI have similar molecules in clinical trials). In addition, Genentech is running several other clinical trials with Apomab in combination with anti-CD20 Abs; Also, Genentech is running similar trials with the trail ligand. Comments appreciated. Have a good weekend.

http://clinicaltrials.gov/ct/show/NCT00497497?order=1

biophud
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up